HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Nakaraang pagsara
$73.64
Sakop ng araw
$73.70 - $75.10
Sakop ng taon
$25.34 - $75.10
Market cap
14.31B USD
Average na Volume
2.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 120.70M | 4,318.01% |
Gastos sa pagpapatakbo | 250.50M | 32.35% |
Net na kita | -182.74M | -12.78% |
Net profit margin | -151.40 | 97.45% |
Kita sa bawat share | -0.72 | 33.41% |
EBITDA | -134.96M | 27.28% |
Aktuwal na % ng binabayarang buwis | 0.83% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 645.94M | 142.54% |
Kabuuang asset | 998.25M | 50.12% |
Kabuuang sagutin | 2.92B | 55.09% |
Kabuuang equity | -1.92B | — |
Natitirang share | 192.71M | — |
Presyo para makapag-book | -7.34 | — |
Return on assets | -32.80% | — |
Return on capital | -4,021.17% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -182.74M | -12.78% |
Cash mula sa mga operasyon | -109.57M | 39.32% |
Cash mula sa pag-invest | 4.46M | -88.32% |
Cash mula sa financing | -894.00K | -226.45% |
Net change in cash | -106.00M | 25.16% |
Malayang cash flow | -74.83M | 28.01% |
Tungkol
CEO
Itinatag
2015
Headquarters
Website
Mga Empleyado
728
